Short-term modification of breathprint by Elexacaftor/Tezacaftor/Ivacaftor in a paediatric cohort
Emmanuelle Bardin(Centre National de la Recherche Scientifique), Isabelle Sermet‐Gaudelus(Hôpital Necker-Enfants Malades), Camille Roquencourt(Hôpital Foch), Philippe Devillier(Université Paris-Saclay), Clément Pontoizeau(Hôpital Necker-Enfants Malades), F. Chedevergne(Hôpital Necker-Enfants Malades), Laurence Le Clainche(Hôpital Robert-Debré), Nicolas Hunzinger(Inserm), Natascha Remus(Hôpital Intercommunal de Créteil), Bingqing Zhou(Inserm), Thao Nguyen‐Khoa(Hôpital Necker-Enfants Malades), Y. Tabache(Hôpital Necker-Enfants Malades), Charlotte Roy(Hôpital Necker-Enfants Malades), Mairead Kelly(Inserm), Elodie Lamy(Inserm), Stanislas Grassin‐Delyle(Inserm)
Cited by 4
Related Papers
<i>Pseudomonas aeruginosa</i>infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches
|Expert Review of Respiratory Medicine|2016|170
<i>Mycobacterium abscessus</i>and Children with Cystic Fibrosis
|Emerging infectious diseases|2003|159
Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis
|FEMS Microbiology Letters|2017|107
Modulators of CFTR. Updates on clinical development and future directions
|European Journal of Medicinal Chemistry|2021|67